Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > New Capital Gains tax rules effective 2024 CRA
View:
Post by james700 on Jun 21, 2023 9:36pm

New Capital Gains tax rules effective 2024 CRA

This appeared in the financial post. Looks like we are going to be paying for the pandemic spending spree.

https://financialpost.com/personal-finance/taxes/alternative-minimum-tax-system-changes-affect-canadians/wcm/a3626eec-19bc-4654-a082-8f482eee3ccf/amp/
Comment by CAinPlap on Jun 22, 2023 10:45am
We can only hope this will affect us as it will mean we have significant capital gains. :)
Comment by 99942Apophis on Jun 22, 2023 12:12pm
CAinPlap you should've put most of your stocks by now into a TFSA , by doing so it doesn't matter how much your holdings appreciate in value you won't have to pay any tax. I think if the CRA tries to change TFSA rules it can only apply to the year 2024 and after so previous contributions prior wouldn't qualify to a tax,  I am not legally qualified this is only in my opinion ...more  
Comment by CAinPlap on Jun 22, 2023 1:24pm
I have as much as my TFSA will allow and have maxed out kids TFSA's as well. :) I am reasonably confident the proposed changes to the AMT will not be affected by capital gains realized in TFSA's or RRSP's. Only will affect non-registered accounts and properties.
Comment by james700 on Jun 23, 2023 2:26pm
Currently if you are day trading, you will NOT be protected by the TFSA umbrella... Can you day trade through your TFSA? While you can buy, sell, and hold stocks within a TFSA, day trading or overly frequent trading through a TFSA may be considered a business activity by the CRA and flagged for audit. RRSPs simply defer your tax obligations and you pay tax on any gains as if it were income ...more  
Comment by thadeush on Jun 23, 2023 9:47pm
There are no rules for the TFSA, only frustratingly fluid interpretations by the CRA. They refuse to define how many trades are allowed in a TFSA so they can spin it however they want. They just 'decide' that you are not using it as 'intended' without clarifying. Best strategy looks like limiting your trades as much as possible based on the fallacy that it's best to just leave ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250